Skip to main content Accessibility help
  • Print publication year: 2014
  • Online publication date: November 2014

Case 34 - Unruptured advanced ectopic pregnancy

from Section I - General gynecology


1.Medical Treatment of Ectopic Pregnancy: A Committee Opinion. American Society for Reproductive Medicine. Fertil Steril 2013;100:638–44.
2. American College of Obstetricians and Gynecologists. Medical Management of Ectopic Pregnancy. ACOG Practice Bulletin No. 94. Obset Gynecol 2008; 111: 1479–85.
3. MenonS, ColinsJ, BarnhartK. Establishing a human chorionic gonadotropin cutoff to guide methotrexate treatment of ectopic pregnancy: a systematic review. Fertil Steril 2007; 87(3): 481–4.
4. LipscombG, McCordM, StovallT, HuffG, PorteraS, LingF. Predictors of success of methotrexate treatment in women with tubal ectopic pregnancies. N Engl J Med 1999; 341: 1974–8.
5. AlleyassinA, KhandemiA, AghahosseiniM, SafdarianL, BadenooshB, HamedEA. Comparison of success rates in the medical management of ectopic pregnancy with single-dose and multiple-dose administration of methotrexate: a prospective randomized clinical trial. Fertil Steril 2006; 85(6): 1661–6.
6. HajeniusPJ, MolF, MolBWJ, BossuytPMM, AnkumWM, Van der VeenF. Interventions for tubal ectopic pregnancy. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD000324. DOI 10.1002/14651858.CD000324.pub2.
7. MoawadN, MahajanS, MonizM, TaylorS, HurdW. Current diagnosis and treatment of interstitial pregnancy. Am J Obstet Gynecol 2010; 202(1): 15–29.